scholarly journals Use of a Vascular Closure Device (AngioSeal) in Endovascular Interventions Performed Through the Popliteal Artery Due to Iliofemoral Artery Occlusion

2021 ◽  
Vol 9 (4) ◽  
pp. 192-199
Author(s):  
Emced Khalil
Keyword(s):  
Popliteal Artery ◽  
Artery Occlusion ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Endovascular Interventions

scholarly journals Successful bailout procedure for acute popliteal artery occlusion associated with EXOSEAL® vascular closure device: a case report

2019 ◽  
Vol 13 (1) ◽  
Author(s):  
Ryota Urata ◽  
Tetsuya Nomura ◽  
Yusuke Hori ◽  
Kenichi Yoshioka ◽  
Hiroshi Kubota ◽  
...  
Keyword(s):  
Case Report ◽  
Popliteal Artery ◽  
Artery Occlusion ◽  
Closure Device ◽  
Vascular Closure Device

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Vascular Closure Device During Percutaneous EVAR and TEVAR Procedures

2020 ◽  
Vol 27 (3) ◽  
pp. 414-420 ◽  
Author(s):  
Zvonimir Krajcer ◽  
David A. Wood ◽  
Neil Strickman ◽  
Nelson Bernardo ◽  
Chris Metzger ◽  
...  
Keyword(s):  
Endovascular Aneurysm Repair ◽  
Major Complication ◽  
Multicenter Trial ◽  
Closure Device ◽  
Study Cohort ◽  
Complication Rates ◽  
Vascular Closure Device ◽  
Primary Analysis ◽  
Femoral Access ◽  
Endovascular Interventions

Purpose: To evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device in patients undergoing percutaneous endovascular aneurysm repair (PEVAR) or thoracic endovascular aortic repair (TEVAR). Materials and Methods: The SAFE MANTA Study ( ClinicalTrials.gov identifier NCT02908880) was a prospective, single-arm, multicenter trial in patients undergoing endovascular interventions using large-bore sheaths (transcatheter aortic valve replacement, PEVAR, or TEVAR) at 20 sites in North America. Patient selection intended to test the MANTA device in populations without morbid obesity, severe calcification, or a severely scarred femoral access area. Of the 263 patients enrolled in the primary analysis cohort, 53 (20.2%) patients (mean age 74.9±8.9 years; 41 men) underwent PEVAR (n=51) or TEVAR (n=2) procedures and form the cohort for this subgroup analysis. Per protocol a single MANTA device was deployed in all PEVAR/TEVAR cases. Results: The mean time to hemostasis in the PEVAR/TEVAR cohort was 35±91 seconds, with a median time of 19 seconds vs 24 seconds in the overall SAFE MANTA population. The MANTA device met the definition for technical success in 52 (98%) of 53 PEVAR/TEVAR cases compared with 97.7% in the overall SAFE MANTA population. One (1.9%) major complication (access-site stenosis) occurred in this subgroup compared to 14 (5.3%) events in the SAFE population. In the PEVAR/TEVAR group, 1 pseudoaneurysm was noted prior to discharge, another at 30-day follow-up, and one at 60 days. One (1.9%) of the 3 minor pseudoaneurysms was treated with ultrasound-guided compression and the other 2 required no treatment. Conclusion: The MANTA device demonstrated a short time to hemostasis and low complication rates compared with published literature results of other percutaneous closure devices. Time to hemostasis and complication rates were comparable between the PEVAR/TEVAR patients and the full SAFE MANTA study cohort. The MANTA device provides reliable closure with a single percutaneous device for PEVAR/TEVAR procedures.

scholarly journals Cutting Balloon Angioplasty to Relieve Femoral Artery Occlusion Associated with a Vascular Closure Device

2009 ◽  
Vol 50 (6) ◽  
pp. 1537 ◽  
Author(s):  
Shane D. O'Keeffe ◽  
Jacob Perry ◽  
David J. Minion ◽  
Eleftherios S. Xenos ◽  
Ehab E. Sorial
Keyword(s):  
Femoral Artery ◽  
Balloon Angioplasty ◽  
Artery Occlusion ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Cutting Balloon ◽  
Femoral Artery Occlusion ◽  
Cutting Balloon Angioplasty

scholarly journals Angioscopic Observation of Acute Femoral Artery Occlusion Complicated by Use of Angio-seal Vascular Closure Device

Angioscopy ◽  
2015 ◽  
Vol 1 (1) ◽  
pp. 35-37
Author(s):  
Ryo Munakata ◽  
Masamichi Takano ◽  
Tomohito Hada ◽  
Tetsuro Shimura ◽  
Osamu Kurihara ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Artery Occlusion ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Femoral Artery Occlusion

scholarly journals Control of local haemostasis with the AngioSeal® vascular closure device in peripheral endovascular interventions via 6-9 F femoral artery access

2012 ◽  
Vol 1 ◽  
pp. 1-7 ◽  
Author(s):  
Roman Machnik ◽  
Piotr Pieniążek ◽  
Piotr Musiałek ◽  
Tadeusz Przewłocki ◽  
Łukasz Tekieli ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Endovascular Interventions

Symptomatic vascular complications after vascular closure device use following diagnostic and interventional catheterisation

VASA ◽  
2004 ◽  
Vol 33 (2) ◽  
pp. 78-81 ◽  
Author(s):  
Thalhammer ◽  
Aschwanden ◽  
Jeanneret ◽  
Labs ◽  
Jäger
Keyword(s):  
Current Literature ◽  
Vascular Complications ◽  
University Hospital ◽  
Closure Device ◽  
Ultrasound Guided ◽  
Vascular Closure Device ◽  
Device Use ◽  
Arterial Stenoses ◽  
The University ◽  
Stenotic Lesions

Background: Haemostatic puncture closure devices for rapid and effective hemostasis after arterial catheterisation are a comfortable alternative to manual compression. Implanting a collagen plug against the vessel wall may become responsible for other kind of vascular injuries i.e. thrombotic or stenotic lesions and peripheral embolisation. The aim of this paper is to report our clinically relevant vascular complications after Angio-Seal® and to discuss the results in the light of the current literature. Patients and methods: We report the symptomatic vascular complications in 17 of 7376 patients undergoing diagnostic or therapeutic catheterisation between May 2000 and March 2003 at the University Hospital Basel. Results: Most patients presented with ischaemic symptoms, arterial stenoses or occlusions and thrombotic lesions (n = 14), whereas pseudoaneurysms were extremely rare (n = 3). Most patients with ischaemic lesions underwent vascular surgery and all patients with a pseudoaneurysm were successfully treated by ultrasound-guided compression. Conclusions: Severe vascular complications after Angio-Seal® are rare, consistent with the current literature. There may be a shift from pseudoaneurysms to ischaemic lesions.

Use of vascular closure devices for endovascular interventions requiring a direct puncture of PETE grafts

VASA ◽  
2018 ◽  
Vol 47 (2) ◽  
pp. 119-124 ◽  
Author(s):  
Artur I. Milnerowicz ◽  
Aleksandra A. Milnerowicz ◽  
Marcin Protasiewicz ◽  
Wiktor Kuliczkowski
Keyword(s):  
Statistical Significance ◽  
Vascular Complications ◽  
Vascular Complication ◽  
Inguinal Region ◽  
Closure Device ◽  
Manual Compression ◽  
Direct Puncture ◽  
Endovascular Interventions ◽  
Vascular Closure Devices ◽  
Closure Group

Abstract. Background: Effectiveness of vascular closure devices during endovascular procedures requiring a direct puncture of a vascular prosthesis placed in the inguinal region is unknown. Patients and methods: The retrospective analysis included 134 patients with a history of polyethylene terephthalate (PETE) graft implantation in the inguinal region. In 20 (15 %) patients, haemostasis was achieved with manual compression, in 21 (16 %) with the StarClose™, and in 93 (69 %) with the AngioSeal™ device. Results: The incidence of vascular complications in the manual compression group was higher (at a threshold of statistical significance) than in the device closure group (45.0 vs. 24.5 %, p = 0.059). The difference was considered statistically significant when manual compression was compared with the AngioSeal™ closure group (45.0 vs. 13.9 %, p < 0.01). The vascular complication rate in the StarClose™ group was significantly higher than in the AngioSeal™ group (71.4 vs. 13.9 %, p < 0.000001). While haematomas were the only vascular complications observed after application of AngioSeal™, both haematomas and pseudoaneurysms were found in the StarClose™ group. Conclusions: The AngioSeal™ vascular closure device provides better local haemostasis than the StarClose™ device or manual compression during endovascular interventions requiring a direct puncture of PETE grafts

Sign in / Sign up

Export Citation Format

Share Document